Medical devices, healthcare technology and the business of care
510(k) clearance · K261892

ProRib Fixation System

Costa Surgical, Inc. · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONK261892

What did the FDA decide?

Costa Surgical, Inc. received a substantially equivalent (SESE) decision for the ProRib Fixation System under 510(k) K261892, dated September 23, 2026, with the application received June 5, 2026. The device is classified as a bone fixation plate (product code HRS, regulation 21 CFR 888.3030) in the Orthopedic specialty, with subsequent product codes HTN and HWC. SESE denotes 510(k) clearance to market, not premarket approval.

The FDA letter describes the ProRib intrathoracic implants as indicated for fixation, stabilization, and fusion of rib fractures and osteotomies, and states the device is substantially equivalent in indications and design. The available excerpts do not identify the predicate device, the specific components or materials, or any performance data supporting equivalence; those details would require the full summary document.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261892
Regulatory pathway
510(k) premarket notification
Product code
HRS
Decision code
SESE
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Plate, Fixation, Bone.

Product code
HRS
FDA device class
2

FDA decision timeline

  1. K261892 received

    Application receipt date recorded by FDA.

  2. K261892 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HRS

Product / regulatory recordCompanyPathwayDecision dateSource
Hero Orthopedics, LLC510(k) clearanceNov 2, 2026FDA
ARTHREX, INC.510(k) clearanceOct 29, 2026FDA
Skeletal Dynamics, Inc.510(k) clearanceOct 26, 2026FDA
GLOBUS MEDICAL, INC.510(k) clearanceOct 23, 2026FDA
Pace Surgical510(k) clearanceOct 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Costa Surgical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Chandler, AZ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records